ebomi
Colour theme
Sign in
Insider · CIK 0001491140

O'Toole David D

CIK 0001491140 Name as filed on the most recent filing

Filed as O'Toole David D (48)

63 transaction lines · from 48 filings · filed 2012-02-06 to 2026-08-24 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

63 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-06-12 P, Open-market purchase Avita Medical, Inc.RCEL 7,940, acquired Open Form 4 filing 0001193125-26-363747
2026-05-20 P, Open-market purchase Avita Medical, Inc.RCEL 8,520, acquired Open Form 4 filing 0001193125-26-232686
2026-05-19 P, Open-market purchase Avita Medical, Inc.RCEL 8,480, acquired Open Form 4 filing 0001193125-26-230874
2026-03-11 P, Open-market purchase Avita Medical, Inc.RCEL 8,604, acquired Open Form 4 filing 0001193125-26-102263
2026-02-19 P, Open-market purchase Avita Medical, Inc.RCEL 12,450, acquired Open Form 4 filing 0001193125-26-064111
2025-08-26 P, Open-market purchase Avita Medical, Inc.RCEL 9,040, acquired Open Form 4 filing 0000950170-25-111467
2025-08-12 P, Open-market purchase Avita Medical, Inc.RCEL 9,620, acquired Open Form 4 filing 0000950170-25-107387
2025-02-20 P, Open-market purchase Avita Medical, Inc.RCEL 9,900, acquired Open Form 4 filing 0000950170-25-024204
2025-02-19 P, Open-market purchase Avita Medical, Inc.RCEL 10,250, acquired Open Form 4 filing 0000950170-25-023233
2024-12-05 P, Open-market purchase Avita Medical, Inc.RCEL 2 lines 12,152, acquired Open Form 4 filing 0000950170-24-133748
2024-05-30 P, Open-market purchase Avita Medical, Inc.RCEL 2 lines 8,900, acquired Open Form 4 filing 0000950170-24-068006
2024-02-28 P, Open-market purchase Avita Medical, Inc.RCEL 2 lines 21,738, acquired Open Form 4 filing 0000950170-24-022050
2023-12-12 P, Open-market purchase Avita Medical, Inc.RCEL 11,828, acquired Open Form 4 filing 0000950170-23-069750
2023-12-01 P, Open-market purchase Avita Medical, Inc.RCEL 5,340, acquired Open Form 4 filing 0000950170-23-067875
2023-11-21 P, Open-market purchase Avita Medical, Inc.RCEL 2 lines 20,560, acquired Open Form 4 filing 0000950170-23-065502
2023-11-16 P, Open-market purchase Avita Medical, Inc.RCEL 12,150, acquired Open Form 4 filing 0000950170-23-064444
2023-11-15 P, Open-market purchase Avita Medical, Inc.RCEL 13,250, acquired Open Form 4 filing 0000950170-23-064208
2023-11-15 P, Open-market purchase Avita Medical, Inc.RCEL 12,450, acquired Open Form 4 filing 0000950170-23-064444
2023-11-14 P, Open-market purchase Avita Medical, Inc.RCEL 12,880, acquired Open Form 4 filing 0000950170-23-064208
2023-08-16 P, Open-market purchase Avita Medical, Inc.RCEL 2 lines 34,110, acquired Open Form 4 filing 0000950170-23-043056
2023-08-15 P, Open-market purchase Avita Medical, Inc.RCEL 5 lines 89,640, acquired Open Form 4 filing 0000950170-23-042840
2023-06-20 P, Open-market purchase Avita Medical, Inc.RCEL 16,150, acquired Open Form 4 filing 0001209191-23-038909
2023-01-27 S, Open-market sale Opiant Pharmaceuticals, Inc.OPNT 10,961, disposed Open Form 4 filing 0001385508-23-000030
2023-01-09 S, Open-market sale Opiant Pharmaceuticals, Inc.OPNT 8,383, disposed Open Form 4 filing 0001385508-23-000024
2023-01-05 S, Open-market sale Opiant Pharmaceuticals, Inc.OPNT 32,320, disposed Open Form 4 filing 0001385508-23-000011
2022-07-14 S, Open-market sale Opiant Pharmaceuticals, Inc.OPNT 8,647, disposed Open Form 4 filing 0001385508-22-000112
2022-01-10 S, Open-market sale Opiant Pharmaceuticals, Inc.OPNT 13,219, disposed Open Form 4 filing 0001385508-22-000022
2021-09-14 P, Open-market purchase Opiant Pharmaceuticals, Inc.OPNT 2 lines 3,824, acquired Open Form 4 filing 0001385508-21-000132
2021-08-16 P, Open-market purchase Opiant Pharmaceuticals, Inc.OPNT 9,228, acquired Open Form 4 filing 0001385508-21-000111
2020-06-11 P, Open-market purchase Opiant Pharmaceuticals, Inc.OPNT 8,740, acquired Open Form 4 filing 0001385508-20-000067
2020-05-26 P, Open-market purchase Opiant Pharmaceuticals, Inc.OPNT 11,000, acquired Open Form 4 filing 0001385508-20-000061
2019-11-26 P, Open-market purchase Opiant Pharmaceuticals, Inc.OPNT 1,322, acquired Open Form 4 filing 0001385508-19-000121
2019-11-15 P, Open-market purchase Opiant Pharmaceuticals, Inc.OPNT 2 lines 16,410, acquired Open Form 4 filing 0001385508-19-000117
2019-08-15 P, Open-market purchase Opiant Pharmaceuticals, Inc.OPNT 15,200, acquired Open Form 4 filing 0001385508-19-000088
2019-08-13 P, Open-market purchase Opiant Pharmaceuticals, Inc.OPNT 15,460, acquired Open Form 4 filing 0001385508-19-000086
2018-08-14 P, Open-market purchase Opiant Pharmaceuticals, Inc.OPNT 2 lines 15,636, acquired Open Form 4 filing 0001385508-18-000071
2018-05-16 P, Open-market purchase Opiant Pharmaceuticals, Inc.OPNT 33,900, acquired Open Form 4 filing 0001385508-18-000045
2018-05-11 P, Open-market purchase Opiant Pharmaceuticals, Inc.OPNT 56,550, acquired Open Form 4 filing 0001385508-18-000041

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 58
  • Open-market sale 5
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. O'Toole David D, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001491140

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.